A 12-year longitudinal study from the US, using data from a large commercial health insurer, showed that among the members who disenrolled from the insurer, over a third (34%) re-enrolled within five years of leaving
According to the CDC, as of 2021, 38.1 million adults (14.7%) in the United States had diabetes, with the incidence increasing with age
The addition of GIP receptor agonism may complement these effects, though the precise contributions of dual receptor activation remain under investigation
The Bottom Line In under two decades, GLP-1 agonists moved from niche diabetes drugs to pillars of cardiometabolic carelowering glucose, reducing weight, and, as SELECT showed, preventing heart attacks
Semaglutide: A study compared liraglutide and semaglutide in terms of efficacy and side effects